Validation of methods for CYP2C9 genotyping: Frequencies of mutant alleles in a Swedish population

Biochemical and Biophysical Research Communications

Volumn 254, Issue 3, 1999, Pages 628-631

  Yasar, Ümit ^a   Eliasson, Erik ^b   Dahl, Marja Liisa ^a   Johansson, Inger ^b   Ingelman Sundberg, Magnus ^b   Sjöqvist, Folke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENOTYPE; HUMAN; MALE; NORMAL HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWEDEN; TECHNIQUE;

EID: 0033608176     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9992     Document Type: Article

References (26)

1. Bertilsson L., Dahl M. L., Johansson I., Ingelman-Sundberg M., Sjöqvist F. Advances in Drug Metabolism in Man. 1995;European Commission, Luxembourg. p. 85-136.
2. Veronese M. E., Mackenzie P. I., Doecke C. J., McManus M. E., Miners J. O., Birkett D. J. Biochem. Biophys. Res. Commun. 175:1991;1112-1118.
3. Rettie A. E., Korzekwa K. R., Kunze K. L., Lawrence R. F., Eddy A. C., Aoyama T., Gelboin H. V., Gonzalez F. J., Trager W. F. Chem. Res. Toxicol. 5:1992;54-59.
4. Relling M. V., Aoyama T., Gonzalez F. J., Meyer U. A. J. Pharmacol. Exp. Ther. 252:1990;442-447.
5. Stearns R. A., Chakravarty P. K., Chen R., Chiu S. H. Drug Metab. Dispos. 23:1995;207-215.
6. Miners J. O., Rees D. L., Valente L., Veronese M. E., Birkett D. J. J. Pharmacol. Exp. Ther. 272:1995;1076-1081.
7. Tracy T. S., Rosenbluth B. W., Wrighton S. A., Gonzalez F. J., Korzekwa K. R. Biochem. Pharmacol. 49:1995;1269-1275.
8. Hamman M. A., Thompson G. A., Hall S. D. Biochem. Pharmacol. 54:1997;33-41.
9. Mancy A., Broto P., Dijols S., Dansette P. M., Mansuy D. Biochemistry. 34:1995;10365-10375.
10. Stubbins M. J., Harries L. W., Smith G., Tarbit M. H., Wolf C. R. Pharmacogenetics. 6:1996;429-439.
11. Sullivan-Klose T. H., Ghanayem B. I., Bell D. A., Zhang Z. Y., Kaminsky L. S., Shenfield G. M., Miners J. O., Birkett D. J., Goldstein J. A. Pharmacogenetics. 6:1996;341-349.
12. Miners J. O., Birkett D. J. Br. J. Clin. Pharmacol. 45:1998;525-538.
13. Veronese M. E., Doecke C. J., Mackenzie P. I., McManus M. E., Miners J. O., Rees D. L., Gasser R., Meyer U. A., Birkett D. J. Biochem. J. 289:1993;533-538.
14. Goldstein J. A., de Morais S. M. Pharmacogenetics. 4:1994;285-299.
15. Kaminsky L. S., de Morais S. M., Faletto M. B., Dunbar D. A., Goldstein J. A. Mol. Pharmacol. 43:1993;234-239.
16. Takahashi H., Kashima T., Nomoto S., Iwade K., Tainaka H., Shimizu T., Nomizo Y., Muramoto N., Kimura S., Echizen H. Pharmacogenetics. 8:1998;365-373.
17. Furuya H., Fernandez-Salguero P., Gregory W., Taber H., Steward A., Gonzalez F. J., Idle J. R. Pharmacogenetics. 5:1995;389-392.
18. Yamazaki H., Inoue K., Shimada T. Xenobiotica. 28:1998;103-115.
19. Takahashi H., Kashima T., Nomizo Y., Muramoto N., Shimizu T., Nasu K., Kubota T., Kimura S., Echizen H. Clin. Pharmacol. Ther. 63:1998;519-528.
20. Aithal G. P., Day C. P., Kesteven P. J. L., Daly A. K. Lancet. 1998.
21. Rettie A. E., Wienkers L. C., Gonzalez F. J., Trager W. F., Korzekwa K. R. Pharmacogenetics. 4:1994;39-42.
22. Crespi C. L., Miller V. P. Pharmacogenetics. 7:1997;203-210.
23. Wang S. L., Huang J., Lai M. D., Tsai J. J. Pharmacogenetics. 5:1995;37-42.
24. Nasu K., Kubota T., Ishizaki T. Pharmacogenetics. 7:1997;405-409.
25. Ackermann E., Cascorbi I., Sachse C., Brockmöller J., Mrozikiewicz P. M., Roots I. Eur. J. Clin. Pharmacol. 52:1997;A71.
26. Spielberg S., McCrea J., Cribb A., Rushmore T., Waldman S., Bjornsson T., Lo M. W. Clin. Pharmacol. Ther. 59:1996;215.